ADIL

Adial Pharmaceuticals
ADIL

Overview Fund Activity

14 hedge funds and large institutions have $2.61M invested in Adial Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
14
Holders Change
+6
Holders Change %
+75%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.04M
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$267K
3
Millennium Management
3
Millennium Management
New York
$201K
4
Jane Street
4
Jane Street
New York
$105K
5
Citadel Advisors
5
Citadel Advisors
Florida
$91K

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$2K
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.04M 303,708 +264,726 +679%
BlackRock
2
BlackRock
New York
$705K 205,684 – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$267K 77,985 +64,404 +474%
Millennium Management
4
Millennium Management
New York
$201K 58,461 +58,461 New
Jane Street
5
Jane Street
New York
$105K 30,703 +30,703 New
Citadel Advisors
6
Citadel Advisors
Florida
$91K 26,492 +26,492 New
Brown Advisory
7
Brown Advisory
Maryland
$89K 26,040 +26,040 New
Two Sigma Investments
8
Two Sigma Investments
New York
$87K 25,472 +13,697 +116%
UBS Group
9
UBS Group
Switzerland
$13K 3,791 +1,068 +39%
LTFS
10
Ladenburg Thalmann Financial Services
Florida
$4K 1,281 +479 +60%
Morgan Stanley
11
Morgan Stanley
New York
$2K 535 -10 -2%
Wells Fargo
12
Wells Fargo
California
$2K 650 +400 +160%
CFGS
13
Concourse Financial Group Securities
Alabama
– – – –
Barclays
14
Barclays
United Kingdom
$0 16 +16 New
Deutsche Bank
15
Deutsche Bank
Germany
$0 200 +200 New